FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and is intended for the treatment of colorectal cancer. For this, an antisense oligonucleotide against SMAD7 is used. Versions of use include the use of a pharmaceutical composition containing an antisense oligonucleotide against SMAD7 or a pharmaceutically acceptable salt thereof at a dose of 100 mcg to 500 mg.
EFFECT: group of inventions widens the range of therapeutic agents.
29 cl, 8 dwg, 9 ex
